The quality of our therapeutic solutions is one of the essential requirements for guaranteeing patient safety and building a relationship of trust with the medical profession.
A fundamental element in ensuring qualitative excellence is strict compliance with industry regulations. In particular, Freia Farmaceutici has adopted, as reference standards for preclinical studies, the Good Laboratories Practices; for clinical studies, the Good Clinical Practices; for all production processes, the Good Manufacturing Practices; and, for distribution, the Good Distribution Practices. Finally, all regulations concerning the supervision of all therapeutic solutions developed form an integral part of our corporate culture.
